comparemela.com

Latest Breaking News On - Harpoon therapeutics - Page 4 : comparemela.com

Merck (MRK) earnings Q1 2024

Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook - Merck & Co (NYSE:MRK)

Merck reported Q1 sales of $15.8 billion, beating estimates, with cancer drug Keytruda driving growth. Company raised full-year revenue and EPS forecasts.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.